Literature DB >> 9129485

A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients.

V Rigalleau1, V Blanchetier, C Combe, C Guillot, G Deleris, J Aubertin, M Aparicio, H Gin.   

Abstract

A low-protein, low-phosphorus diet (LPD) has been shown to improve insulin sensitivity in uremic patients; however, this improvement has not been studied at low physiologic concentrations of plasma insulin, and the metabolic pathways concerned with this improvement have not been located. We used the glucose clamp technique at a low (0.25 mU.kg-1.min-1) level of hyperinsulinemia associated with the infusion of D[6,6-2H2] glucose to assess the insulin sensitivity of endogenous glucose production (EGP). Eight nondialyzed uremic patients were studied before and after 3 mo on an LPD providing 0.3 g/kg protein, 5-7 mg P/kg, and 146 kJ/kg (67% of energy as carbohydrates and 30% as lipids) per day, supplemented with ketoanalog amino acids. Postabsorptive plasma glucose and insulin declined after 3 mo of the diet (plasma glucose: 5.0 +/- 0.1 mmol/L before compared with 4.7 +/- 0.1 mmol/L after the LPD, P < 0.05; plasma insulin: 82.4 +/- 20.7 pmol/L before compared with 48.8 +/- 6.0 pmol/L after, P < 0.05). Postabsorptive glucose turnover rates did not change with the diet (2.06 +/- 0.14 mg.kg-1.min-1 before compared with 2.11 +/- 0.17 mg.kg-1.min-1 after LPD; NS). The insulin metabolic clearance rate was enhanced after the diet, so a lower level of hyperinsulinemia was obtained during the clamp (168.8 +/- 28.1 pmol/L before compared with 115.2 +/- 14.7 pmol/L after; P < 0.05). However, EGP was more easily inhibited after the diet (0.90 +/- 0.31 mg.kg-1.min-1 before compared with 0.30 +/- 0.17 mg.kg-1.min-1 after; P < 0.05), providing evidence of an improved insulin sensitivity of this parameter. This beneficial influence takes place at a physiologic level of hyperinsulinemia, and it probably plays an important role in the better glucose tolerance that has been reported in uremic patients on an LPD. An abnormal insulin sensitivity of EGP may participate in the disturbances of glucose metabolism in chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129485     DOI: 10.1093/ajcn/65.5.1512

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  13 in total

1.  Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice.

Authors:  Fengmin Li; Jian Yang; Van Anthony M Villar; Laureano D Asico; Xiaobo Ma; Ines Armando; Hironobu Sanada; Minoru Yoneda; Robin A Felder; Pedro A Jose; Xiaoyan Wang
Journal:  Diabetologia       Date:  2017-10-28       Impact factor: 10.122

Review 2.  Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field.

Authors:  Natasha Dave; Jiao Wu; Sandhya Thomas
Journal:  Curr Diab Rep       Date:  2018-06-08       Impact factor: 4.810

3.  [Low protein diet in the treatment of chronic renal failure: effective, but barely used].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  Ketoacid Supplementation Partially Improves Metabolic Parameters in Patients on Peritoneal Dialysis.

Authors:  Jie Dong; Yan-Jun Li; Rong Xu; Talat Alp Ikizler; Hai-Yan Wang
Journal:  Perit Dial Int       Date:  2015-09-15       Impact factor: 1.756

Review 5.  Current Uses of Dietary Therapy for Patients with Far-Advanced CKD.

Authors:  Norio Hanafusa; Bereket Tessema Lodebo; Joel D Kopple
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-22       Impact factor: 8.237

6.  Quantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniques.

Authors:  John G Hattersley; Matthias Möhlig; Michael Roden; Ayman M Arafat; Christian V Loeffelholz; Peter Nowotny; Jürgen Machann; Johannes Hierholzer; Martin Osterhoff; Michael Khan; Andreas F H Pfeiffer; Martin O Weickert
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

7.  Effects of Low-Protein, and Supplemented Very Low-Protein Diets, on Muscle Protein Turnover in Patients With CKD.

Authors:  Giacomo Garibotto; Antonella Sofia; Emanuele Luigi Parodi; Francesca Ansaldo; Alice Bonanni; Daniela Picciotto; Alessio Signori; Monica Vettore; Paolo Tessari; Daniela Verzola
Journal:  Kidney Int Rep       Date:  2018-01-11

Review 8.  How important is dietary management in chronic kidney disease progression? A role for low protein diets.

Authors:  Gang-Jee Ko; Kamyar Kalantar-Zadeh
Journal:  Korean J Intern Med       Date:  2021-06-22       Impact factor: 2.884

9.  Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease.

Authors:  Sandhya S Thomas; Yanjun Dong; Liping Zhang; William E Mitch
Journal:  Kidney Int       Date:  2013-03-20       Impact factor: 10.612

10.  Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease.

Authors:  Vincenzo Bellizzi; Patrizia Calella; Julia Nava Hernández; Verónica Figueroa González; Silvia Moran Lira; Serena Torraca; Rocio Urbina Arronte; Pietro Cirillo; Roberto Minutolo; Rafael A Montúfar Cárdenas
Journal:  BMC Nephrol       Date:  2018-05-09       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.